Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 13, 2026
From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
New
Compared with the manager's Q2 2026 13F
75,000
0.01%
Within the filing's reported positions, not the manager's total assets
1
For Q3 2026
Insider buying
2 days before resultsTraded Nov 10 · filed 1 day later
An Electra Therapeutics director paid $175K out of pocket for Electra Therapeutics shares. 1 other person at Electra Therapeutics bought some too, in the same month.
Insider buying
3 days before resultsTraded Nov 9 · filed 2 days later
An Electra Therapeutics director paid $33K out of pocket for Electra Therapeutics shares. 1 other person at Electra Therapeutics bought some too, in the same month.
Insider buying
2 days before resultsTraded Nov 10 · filed 1 day later
An Electra Therapeutics director paid $175K out of pocket for Electra Therapeutics shares. 1 other person at Electra Therapeutics bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.